The UK government has announced its future strategy for batch testing of medicinal products. The new strategy means that the UK will continue to recognise batch testing from the EU/EEA, rather than insisting on duplicative batch testing operations. Post-BREXIT, the pharmaceutical industry urged the UK and the EU to sign a Mutual Recognition Agreement (MRA) […]
